LOW-DOSE INTERLEUKIN-2 IN THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA

被引：0
作者：
STADLER, WM
VOGELZANG, NJ
机构：
来源：
SEMINARS IN ONCOLOGY | 1995年 / 22卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：67 / 73
页数：7
相关论文
共 81 条
[1]   HIGH-DOSE RECOMBINANT INTERLEUKIN-2 ALONE - A REGIMEN WITH LIMITED ACTIVITY IN THE TREATMENT OF ADVANCED RENAL-CELL CARCINOMA [J].
ABRAMS, JS ;
RAYNER, AA ;
WIERNIK, PH ;
PARKINSON, DR ;
EISENBERGER, M ;
ARONSON, FR ;
GUCALP, R ;
ATKINS, MB ;
HAWKINS, MJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (14) :1202-1206
[2]   RANDOMIZED PHASE-II TRIAL OF HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON-ALFA-2B IN ADVANCED RENAL-CELL CARCINOMA [J].
ATKINS, MB ;
SPARANO, J ;
FISHER, RI ;
WEISS, GR ;
MARGOLIN, KA ;
FINK, KI ;
RUBINSTEIN, L ;
LOUIE, A ;
MIER, JW ;
GUCALP, R ;
SOSMAN, JA ;
BOLDT, DH ;
DOROSHOW, JH ;
ARONSON, FR ;
SZNOL, M .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) :661-670
[3]  
ATZPODIEN J, 1991, SEMIN ONCOL, V18, P108
[4]  
ATZPODIEN J, 1990, Molecular Biotherapy, V2, P18
[5]  
BERD D, 1984, CANCER RES, V44, P1275
[6]  
BOLDT DH, 1988, CANCER RES, V48, P4409
[7]  
BOLDT DH, 1993, THERAPEUTIC APPLICAT, V2, P73
[8]  
BUDD GT, 1989, CANCER RES, V49, P6432
[9]   PHASE-II TRIAL OF HIGH-DOSE INTERMITTENT INTERLEUKIN-2 IN METASTATIC RENAL-CELL CARCINOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY [J].
BUKOWSKI, RM ;
GOODMAN, P ;
CRAWFORD, ED ;
SERGI, JS ;
REDMAN, BG ;
WHITEHEAD, RP .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (02) :143-146
[10]   AUGMENTATION OF THE ANTI-TUMOR THERAPEUTIC EFFICACY OF LONG-TERM CULTURED LYMPHOCYTES-T BY INVIVO ADMINISTRATION OF PURIFIED INTERLEUKIN-2 [J].
CHEEVER, MA ;
GREENBERG, PD ;
FEFER, A ;
GILLIS, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (04) :968-980
123456789